These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 31116151

  • 21. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
    Wurdeman RL, Mooss AN, Mohiuddin SM, Lucas BD, Ryschon KL, Hilleman DE.
    Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
    [Abstract] [Full Text] [Related]

  • 22. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. Doxazosin Investigators' Study Group.
    Os I, Stokke HP.
    J Cardiovasc Pharmacol; 1999 May; 33(5):791-7. PubMed ID: 10226868
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.
    Hernández RH, Armas-Hernández MJ, Chourio JA, Armas-Padilla MC, López L, Alvarez M, Pacheco B.
    Blood Press Monit; 2001 Feb; 6(1):47-57. PubMed ID: 11248761
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Correlation between short-term blood pressure variability parameters with mobil-O-graph pulse wave velocity.
    Silva MAV, Resende LAPR, Vieira MM, Jajah CBF, Berzotti LA, Rambourg NC, de Souza Pierson ID, Achkar JLC, Vieira LM, Moreira GM, Borges GR, Correia D.
    Clin Hypertens; 2022 Feb 15; 28(1):5. PubMed ID: 35164879
    [Abstract] [Full Text] [Related]

  • 33. Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study.
    Park JB, Shin JH, Kim DS, Youn HJ, Park SW, Shim WJ, Park CG, Kim DW, Lee HY, Choi DJ, Rim SJ, Lee SY, Kim JH, FOCUS Investigators.
    Clin Ther; 2016 Apr 15; 38(4):832-42. PubMed ID: 26996246
    [Abstract] [Full Text] [Related]

  • 34. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Giordano M, Sanders LR, Castellino P, Canessa ML, DeFronzo RA.
    Nephron; 1996 Apr 15; 72(3):447-53. PubMed ID: 8852495
    [Abstract] [Full Text] [Related]

  • 35. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G, Parati G, Bilo G, Choi J, Kilama MO, Ruilope LM, TALENT investigators.
    J Hypertens; 2011 Mar 15; 29(3):600-9. PubMed ID: 21252701
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E, Zulli R, Muiesan ML, Salvetti M, Rizzoni D, Corbellini C, Monteduro C.
    Blood Press; 1998 May 15; 7(3):160-9. PubMed ID: 9758086
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.